Prothena Corporation plc (PRTA)
USD 10.89
(-3.8%)
USD 10.89
(-3.8%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -608.34 Million USD | 13.58% |
| 2022 | -703.93 Million USD | -24.2% |
| 2021 | -566.76 Million USD | -104.21% |
| 2020 | -277.54 Million USD | 21.33% |
| 2019 | -352.78 Million USD | 6.2% |
| 2018 | -376.11 Million USD | -2.94% |
| 2017 | -365.37 Million USD | -8.87% |
| 2016 | -335.6 Million USD | 9.44% |
| 2015 | -370.58 Million USD | -26.23% |
| 2014 | -293.57 Million USD | -66.17% |
| 2013 | -176.67 Million USD | -41.5% |
| 2012 | -124.86 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -552 Million USD | -3.37% |
| 2024 Q1 | -534.01 Million USD | 12.22% |
| 2023 Q4 | -608.34 Million USD | 7.85% |
| 2023 FY | -608.34 Million USD | 13.58% |
| 2023 Q2 | -655.66 Million USD | 3.76% |
| 2023 Q1 | -681.29 Million USD | 3.22% |
| 2023 Q3 | -660.16 Million USD | -0.69% |
| 2022 Q4 | -703.93 Million USD | -44.37% |
| 2022 Q1 | -532.11 Million USD | 6.12% |
| 2022 FY | -703.93 Million USD | -24.2% |
| 2022 Q3 | -487.59 Million USD | 2.33% |
| 2022 Q2 | -499.21 Million USD | 6.18% |
| 2021 Q3 | -586.34 Million USD | -52.42% |
| 2021 Q2 | -384.68 Million USD | -17.82% |
| 2021 Q4 | -566.76 Million USD | 3.34% |
| 2021 Q1 | -326.49 Million USD | -17.64% |
| 2021 FY | -566.76 Million USD | -104.21% |
| 2020 Q3 | -295.36 Million USD | 5.78% |
| 2020 FY | -277.54 Million USD | 21.33% |
| 2020 Q2 | -313.48 Million USD | 5.29% |
| 2020 Q1 | -330.98 Million USD | 6.18% |
| 2020 Q4 | -277.54 Million USD | 6.03% |
| 2019 Q2 | -372.78 Million USD | 2.82% |
| 2019 Q4 | -352.78 Million USD | 3.65% |
| 2019 FY | -352.78 Million USD | 6.2% |
| 2019 Q3 | -366.14 Million USD | 1.78% |
| 2019 Q1 | -383.59 Million USD | -1.99% |
| 2018 Q1 | -376.83 Million USD | -3.14% |
| 2018 FY | -376.11 Million USD | -2.94% |
| 2018 Q4 | -376.11 Million USD | 5.88% |
| 2018 Q3 | -399.59 Million USD | 7.94% |
| 2018 Q2 | -434.04 Million USD | -15.18% |
| 2017 FY | -365.37 Million USD | -8.87% |
| 2017 Q1 | -454.81 Million USD | -35.52% |
| 2017 Q2 | -419.58 Million USD | 7.75% |
| 2017 Q3 | -403.78 Million USD | 3.76% |
| 2017 Q4 | -365.37 Million USD | 9.51% |
| 2016 Q1 | -474.25 Million USD | -27.97% |
| 2016 FY | -335.6 Million USD | 9.44% |
| 2016 Q2 | -407.01 Million USD | 14.18% |
| 2016 Q4 | -335.6 Million USD | 9.1% |
| 2016 Q3 | -369.21 Million USD | 9.29% |
| 2015 Q1 | -279.85 Million USD | 4.67% |
| 2015 Q4 | -370.58 Million USD | 4.44% |
| 2015 FY | -370.58 Million USD | -26.23% |
| 2015 Q3 | -387.8 Million USD | 3.63% |
| 2015 Q2 | -402.38 Million USD | -43.78% |
| 2014 Q1 | -195.05 Million USD | -10.4% |
| 2014 Q4 | -293.57 Million USD | 4.11% |
| 2014 Q3 | -306.15 Million USD | -0.76% |
| 2014 FY | -293.57 Million USD | -66.17% |
| 2014 Q2 | -303.85 Million USD | -55.78% |
| 2013 Q1 | -119.56 Million USD | 4.24% |
| 2013 Q2 | -112.5 Million USD | 5.9% |
| 2013 Q3 | -101.85 Million USD | 9.46% |
| 2013 Q4 | -176.67 Million USD | -73.45% |
| 2013 FY | -176.67 Million USD | -41.5% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | -124.86 Million USD | 0.0% |
| 2012 FY | -124.86 Million USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -987.499% |
| Alkermes plc | -166.73 Million USD | -264.85% |
| Agenus Inc. | 274.13 Million USD | 321.914% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 132.533% |
| Aptorum Group Limited | 1.35 Million USD | 44928.768% |
| Ardelyx, Inc. | 34.51 Million USD | 1862.712% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 14313.715% |
| Bicycle Therapeutics plc | -481.46 Million USD | -26.353% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1782.236% |
| ChromaDex Corporation | -24.04 Million USD | -2429.72% |
| Chimerix, Inc. | -25.51 Million USD | -2284.085% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 8830.487% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -2469.358% |
| CRISPR Therapeutics AG | -150.84 Million USD | -303.293% |
| Precision BioSciences, Inc. | -85.41 Million USD | -612.267% |
| Dyadic International, Inc. | -6.37 Million USD | -9438.061% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -3718.157% |
| Fortress Biotech, Inc. | 7.66 Million USD | 8036.686% |
| Lantern Pharma Inc. | -21.7 Million USD | -2703.019% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -450.356% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -7020.853% |
| Incyte Corporation | -3.17 Billion USD | 80.84% |
| IO Biotech, Inc. | -140.69 Million USD | -332.375% |
| Jaguar Health, Inc. | 29.39 Million USD | 2169.841% |
| Novavax, Inc. | -298.29 Million USD | -103.942% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 11498.67% |
| Opthea Limited | 28.15 Million USD | 2260.519% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -3523.486% |
| ContextLogic Inc. | -232 Million USD | -162.219% |
| MiMedx Group, Inc. | -33.9 Million USD | -1694.481% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 6067.111% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -26155.499% |
| NextCure, Inc. | -6.47 Million USD | -9292.419% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -1104.624% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -9436.714% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 5101.51% |
| Vaxcyte, Inc. | -368.22 Million USD | -65.21% |
| PDS Biotechnology Corporation | -32.7 Million USD | -1759.882% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 3620.934% |
| Pharming Group N.V. | 109.8 Million USD | 654.03% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -3397.051% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -247.171% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -3184.837% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -3184.837% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -8468.268% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -10281.348% |
| Acelyrin, Inc. | -216.9 Million USD | -180.47% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -10743.459% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -35186.949% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1854.476% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -8842.334% |
| Senti Biosciences, Inc. | 1.74 Million USD | 35062.471% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -229.536% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -685.46% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -9935.417% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 609855.535% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 96970.541% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -419.75% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -261.61% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 648.703% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -7908.781% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -371.17% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 8923.531% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -151.007% |
| Immix Biopharma, Inc. | -17.5 Million USD | -3374.325% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -92.088% |
| MEI Pharma, Inc. | -3.7 Million USD | -16319.622% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 4962.497% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 476.122% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 2288.85% |
| Fortress Biotech, Inc. | 7.66 Million USD | 8036.686% |
| Precigen, Inc. | -481 Thousand USD | -126375.468% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 4420.339% |
| AlloVir, Inc. | -62.69 Million USD | -870.374% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -993.874% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 1086.519% |
| ImmuCell Corporation | 10.99 Million USD | 5635.176% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -294.656% |
| Onconetix, Inc. | 5.33 Million USD | 11510.563% |
| PureTech Health plc | -167.19 Million USD | -263.85% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1897.2% |
| Elevation Oncology, Inc. | -19.11 Million USD | -3082.064% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -12292.483% |
| Seer, Inc. | -4.24 Million USD | -14247.807% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -2430.877% |
| Innoviva, Inc. | 255.56 Million USD | 338.042% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -988.979% |
| ESSA Pharma Inc. | -33.62 Million USD | -1709.394% |
| GlycoMimetics, Inc. | -40.98 Million USD | -1384.337% |
| GT Biopharma, Inc. | -1.02 Million USD | -59483.448% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -797.492% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 1093.106% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -353.723% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -4290.495% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -2007.048% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -807433.119% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1871.185% |
| Aptose Biosciences Inc. | -8.19 Million USD | -7323.522% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -19342.106% |
| Soligenix, Inc. | -4.95 Million USD | -12185.875% |
| Century Therapeutics, Inc. | 847 Thousand USD | 71923.731% |
| Kura Oncology, Inc. | -20.11 Million USD | -2923.894% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -1386.456% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -7143.951% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 33494.558% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -18928.683% |
| Autolus Therapeutics plc | -186.59 Million USD | -226.018% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -1133.869% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -120.58% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1875.263% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 470.113% |
| GRI Bio, Inc. | -1.79 Million USD | -33810.089% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -6672.168% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -1729.23% |
| IGM Biosciences, Inc. | -72.6 Million USD | -737.874% |
| INmune Bio, Inc. | -25.41 Million USD | -2294.03% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 503.01% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -1100.866% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -3643.819% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -20987.092% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1700.281% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -1377.108% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 2007.941% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 260.959% |
| Verastem, Inc. | -37.27 Million USD | -1531.92% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -6605.026% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -1073.011% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -3919.471% |
| Histogen Inc. | -7.48 Million USD | -8025.377% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -2715.532% |
| Surrozen, Inc. | -32.66 Million USD | -1762.439% |
| Organovo Holdings, Inc. | -1.5 Million USD | -40268.082% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -14372.433% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 3308.546% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 23354.855% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 14737.801% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -7158.515% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -1300.366% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -4073.375% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -92.035% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -84151.586% |
| Apollomics, Inc. | -27.39 Million USD | -2120.65% |
| Amarin Corporation plc | -191.04 Million USD | -218.44% |
| Mesoblast Limited | 55.96 Million USD | 1187.052% |
| Turnstone Biologics Corp. | -14.58 Million USD | -4071.332% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -2305.294% |
| Synaptogenix, Inc. | -28.66 Million USD | -2022.523% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -64894.338% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 1348.352% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -70466.612% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -8272.424% |
| Exelixis, Inc. | -73.05 Million USD | -732.782% |
| Better Therapeutics, Inc. | -860 Thousand USD | -70638.023% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -2433.407% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -152.038% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 82748.431% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -8078.757% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 48612.52% |
| Gritstone bio, Inc. | 39.49 Million USD | 1640.509% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -623.353% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -23012.258% |
| Avid Bioservices, Inc. | 169.72 Million USD | 458.425% |
| Insmed Incorporated | 721.62 Million USD | 184.303% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -6554.774% |
| MediWound Ltd. | -5.32 Million USD | -11330.797% |
| OmniAb, Inc. | 9.2 Million USD | 6710.312% |
| Alector, Inc. | -35.63 Million USD | -1607.066% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 807.619% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -12244.704% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 4695.113% |
| Zai Lab Limited | -775 Million USD | 21.504% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 278.634% |
| Aura Biosciences, Inc. | -21.52 Million USD | -2726.235% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -637.569% |
| Immunic, Inc. | -45.34 Million USD | -1241.745% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -214.855% |
| Veracyte, Inc. | -203.82 Million USD | -198.467% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 195.308% |
| FibroGen, Inc. | 56.76 Million USD | 1171.656% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 6931.522% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -21418.548% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -29283.804% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 113.253% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -18108.53% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -266.554% |
| TG Therapeutics, Inc. | 17.86 Million USD | 3505.817% |
| Galecto, Inc. | -21.21 Million USD | -2767.397% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -2457.692% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 138.763% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -2385.89% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -5186.756% |
| XBiotech Inc. | -200.02 Million USD | -204.139% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -623.353% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 13535.225% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -1625.171% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -687.831% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 10789.633% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -256.98% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -558.57% |
| Vaxxinity, Inc. | 10.13 Million USD | 6104.214% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 182.626% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -5549.818% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -822.353% |
| NexImmune, Inc. | -3.13 Million USD | -19313.411% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -17519.595% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -3925.735% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -2144.823% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -6677.444% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -488237.949% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -1399.426% |
| Ainos, Inc. | 4.07 Million USD | 15018.042% |
| Pluri Inc. | 22.82 Million USD | 2764.799% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -412.266% |
| Celularity Inc. | 65.19 Million USD | 1033.191% |
| Rallybio Corporation | -24.1 Million USD | -2424.052% |
| Cue Biopharma, Inc. | -33.81 Million USD | -1698.832% |
| MeiraGTx Holdings plc | -40.3 Million USD | -1409.471% |
| Omeros Corporation | 331.17 Million USD | 283.693% |
| Humacyte, Inc. | -22.48 Million USD | -2605.448% |
| Immunocore Holdings plc | -358.59 Million USD | -69.648% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -2375.471% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1868.697% |
| Blueprint Medicines Corporation | 702.83 Million USD | 186.556% |
| CalciMedica, Inc. | -5.53 Million USD | -10900.85% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -223.211% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -5856.011% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -1419.462% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -1729.45% |
| Pulmatrix, Inc. | -10.41 Million USD | -5739.944% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -10078.133% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -1494.953% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -446.083% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -914.859% |
| Cytokinetics, Incorporated | 642.37 Million USD | 194.703% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -10347.312% |
| Nutriband Inc. | -251.65 Thousand USD | -241636.57% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -1683.015% |
| Vor Biopharma Inc. | 4.3 Million USD | 14247.605% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 89.921% |
| Evogene Ltd. | -19.63 Million USD | -2998.436% |
| ProKidney Corp. | -56.23 Million USD | -981.775% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -1149.891% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -6485.847% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 144.603% |
| CorMedix Inc. | -43.05 Million USD | -1313.035% |
| BioLineRx Ltd. | 7.33 Million USD | 8392.625% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -2114.99% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 1418.281% |
| Atai Life Sciences N.V. | -28.55 Million USD | -2030.216% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 27373.665% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -2566.317% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 3530.206% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -710.33% |
| MediciNova, Inc. | -50.78 Million USD | -1097.922% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -671.965% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -2704265.415% |
| GeoVax Labs, Inc. | -6.45 Million USD | -9327.952% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -204.446% |
| Biomea Fusion, Inc. | -166.57 Million USD | -265.22% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -239.906% |
| Mereo BioPharma Group plc | -51.46 Million USD | -1081.968% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -541.419% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -107.091% |
| Absci Corporation | -72.59 Million USD | -737.967% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 13423.412% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -159.493% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -545.728% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -535.708% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -1456.95% |
| Allakos Inc. | -24.97 Million USD | -2335.824% |
| Imunon, Inc. | -4.21 Million USD | -14336.838% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -4026.625% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -349.296% |
| BioAtla, Inc. | -109.01 Million USD | -458.06% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 82748.431% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -64686.688% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 5183.963% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -2769.155% |
| XOMA Corporation | -29 Million USD | -1997.748% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -3573.593% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -6647.416% |
| aTyr Pharma, Inc. | -7.44 Million USD | -8066.828% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -388.099% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -192.244% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -643.891% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -555.808% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -70705.206% |
| Akari Therapeutics, Plc | -3.84 Million USD | -15721.769% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 37585.412% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 144.055% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -51101.842% |
| UroGen Pharma Ltd. | 4.39 Million USD | 13954.407% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 636.078% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 845472.558% |
| Orgenesis Inc. | 21.78 Million USD | 2892.632% |
| Entera Bio Ltd. | -10.62 Million USD | -5623.464% |
| GH Research PLC | -78.07 Million USD | -679.163% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -2629.482% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -2181.957% |
| Xencor, Inc. | 29.64 Million USD | 2152.176% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -30783.506% |
| Replimune Group, Inc. | 1.41 Million USD | 43184.065% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -248298.174% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -381.222% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -51101.842% |
| Portage Biotech Inc. | -4.98 Million USD | -12113.351% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -2704265.415% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -820.037% |
| OncoCyte Corporation | -6.56 Million USD | -9169.343% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 67888.967% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -13253.702% |
| Purple Biotech Ltd. | -14.13 Million USD | -4202.921% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -2460.814% |
| scPharmaceuticals Inc. | -6.54 Million USD | -9194.836% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -3544.506% |
| HilleVax, Inc. | -165.48 Million USD | -267.615% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -23869.543% |
| Tharimmune, Inc. | -10.93 Million USD | -5463.122% |
| Genprex, Inc. | -6.73 Million USD | -8929.096% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -64.95% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -587.709% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -43322.341% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -18240.576% |
| OKYO Pharma Limited | -826.84 Thousand USD | -73474.224% |
| Savara Inc. | 153 Thousand USD | 397712.418% |
| Curis, Inc. | -23.88 Million USD | -2446.77% |
| Daré Bioscience, Inc. | -5.15 Million USD | -11694.445% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -78294.02% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -9699.404% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 51437.3% |
| BeiGene, Ltd. | -2.25 Billion USD | 72.999% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 5030.478% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -0.024% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -227.798% |
| Erasca, Inc. | -37.21 Million USD | -1534.638% |
| bluebird bio, Inc. | 108.57 Million USD | 660.322% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -47135.834% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 260.621% |
| DBV Technologies S.A. | -126.98 Million USD | -379.066% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -47135.834% |
| Moderna, Inc. | -2.9 Billion USD | 79.073% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -5776.613% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -5497.598% |
| Molecular Templates, Inc. | 707 Thousand USD | 86146.252% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1839.202% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 275.514% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -641.326% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -563.193% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1785.061% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -1669.685% |
| MacroGenics, Inc. | -66.98 Million USD | -808.184% |
| RenovoRx, Inc. | -1.17 Million USD | -51762.489% |
| Adicet Bio, Inc. | -138.78 Million USD | -338.331% |
| Prime Medicine, Inc. | -27.94 Million USD | -2077.256% |
| Aditxt, Inc. | 18.12 Million USD | 3457.159% |
| Adagene Inc. | -87.62 Million USD | -594.243% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -14504.67% |
| Quantum-Si incorporated | -118.55 Million USD | -413.126% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1789.618% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -8039.306% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -1154.091% |
| SciSparc Ltd. | -2.06 Million USD | -29359.903% |
| Vericel Corporation | 1.27 Million USD | 47738.763% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -4973.067% |
| Minerva Neurosciences, Inc. | 41 Million USD | 1583.619% |
| Generation Bio Co. | 31.44 Million USD | 2034.454% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -246.905% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1867.296% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 621.77% |
| Invivyd, Inc. | -198.47 Million USD | -206.509% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -573.919% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -25272.231% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -759.369% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -8813.509% |
| 2seventy bio, Inc. | 181.71 Million USD | 434.781% |
| ADMA Biologics, Inc. | 90.06 Million USD | 775.446% |
| Clene Inc. | 3.34 Million USD | 18313.982% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -6597.863% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -2728.074% |
| GeoVax Labs, Inc. | -6.45 Million USD | -9327.952% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -76.781% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -2239.825% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 442.41% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -14768.313% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 12262.075% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -11578.768% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -366.867% |
| Evaxion Biotech A/S | 5.28 Million USD | 11606.808% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -440.426% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -363.421% |
| Trevena, Inc. | 2.25 Million USD | 27041.851% |
| Surrozen, Inc. | -32.66 Million USD | -1762.439% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -1081.027% |
| Cingulate Inc. | 3.08 Million USD | 19834.335% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -20613.211% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 8564.547% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -6447.542% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -666.924% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -362.79% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -476.403% |
| Clearmind Medicine Inc. | -3.94 Million USD | -15329.952% |
| Kronos Bio, Inc. | -36.05 Million USD | -1587.322% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 6565.586% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 41821.126% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -1021.253% |
| Statera Biopharma, Inc. | 14.41 Million USD | 4319.824% |
| ImmunityBio, Inc. | 618.22 Million USD | 198.402% |
| Korro Bio, Inc. | -132.94 Million USD | -357.6% |
| Kineta, Inc. | -4.54 Million USD | -13296.763% |
| BioVie Inc. | -17.73 Million USD | -3330.718% |
| Codexis, Inc. | -43.27 Million USD | -1305.9% |
| Celularity Inc. | 65.19 Million USD | 1033.191% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -19096.813% |
| Celcuity Inc. | 6.78 Million USD | 9068.028% |
| Virax Biolabs Group Limited | -3.36 Million USD | -17978.964% |
| Cibus, Inc. | -8.07 Million USD | -7430.911% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -14285.127% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 13411.751% |
| IN8bio, Inc. | -16.38 Million USD | -3611.923% |
| Kodiak Sciences Inc. | -103.87 Million USD | -485.653% |
| Annexon, Inc. | -193.75 Million USD | -213.977% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 1689952.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -3376.467% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -17217.022% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 157.703% |
| Eyenovia, Inc. | 1.25 Million USD | 48431.297% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 2361.093% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -18658.773% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -1729.78% |
| Arcellx, Inc. | -296.95 Million USD | -104.86% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -3018.769% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -933.286% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -2835.046% |
| Moolec Science SA | 117.61 Thousand USD | 517331.499% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -1484.278% |
| Geron Corporation | 14.76 Million USD | 4221.313% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -1504.375% |
| Royalty Pharma plc | 5.65 Billion USD | 110.751% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -330.167% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -8603.822% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -11243.707% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -332.276% |
| Humacyte, Inc. | -22.48 Million USD | -2605.448% |
| Structure Therapeutics Inc. | -124.33 Million USD | -389.265% |
| 89bio, Inc. | -289.05 Million USD | -110.462% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -2310.059% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -34019.293% |
| Genelux Corporation | -6.89 Million USD | -8717.901% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1858.682% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 827.697% |
| Notable Labs, Ltd. | -9.77 Million USD | -6122.862% |
| Liquidia Corporation | -80.17 Million USD | -658.764% |
| Mustang Bio, Inc. | -3.73 Million USD | -16183.378% |
| Immunovant, Inc. | -635.22 Million USD | 4.232% |
| Quantum-Si incorporated | -118.55 Million USD | -413.126% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -3363.602% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -14583.732% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 7678.759% |
| Acasti Pharma Inc. | -23 Million USD | -2544.412% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -17966.695% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -3643.819% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -341.663% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -19421.063% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -2636.358% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -3176.143% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -259.377% |
| PepGen Inc. | -60.67 Million USD | -902.715% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -2547.75% |
| United Therapeutics Corporation | -507.7 Million USD | -19.824% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -3080.733% |
| Solid Biosciences Inc. | -47.75 Million USD | -1174.025% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -70466.612% |
| Immuneering Corporation | -54.94 Million USD | -1007.236% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -14372.433% |
| Silo Pharma, Inc. | -3.52 Million USD | -17161.46% |
| Belite Bio, Inc | -87.27 Million USD | -597.078% |
| XOMA Corporation | -29 Million USD | -1997.748% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -760.499% |
| Bionomics Limited | 227 Million USD | 367.983% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -423.165% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -23916.857% |
| uniQure N.V. | -102.95 Million USD | -490.909% |
| Cassava Sciences, Inc. | -121.13 Million USD | -402.202% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -14504.67% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 1585.549% |
| Forte Biosciences, Inc. | -11.96 Million USD | -4986.088% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -19560.882% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 574012.264% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -18658.773% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 6931.522% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -8103.169% |
| Altimmune, Inc. | -134.48 Million USD | -352.346% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 407.145% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -23916.857% |
| Compugen Ltd. | -12.9 Million USD | -4614.406% |
| Peak Bio, Inc. | 10.34 Million USD | 5983.343% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -214863.604% |
| Benitec Biopharma Inc. | -50.58 Million USD | -1102.695% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -483.054% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 3196.701% |
| Zura Bio Limited | -99.8 Million USD | -509.529% |
| PolyPid Ltd. | 6.17 Million USD | 9959.757% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 920.76% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 3196.701% |
| Instil Bio, Inc. | 75.35 Million USD | 907.276% |
| argenx SE | -2.02 Billion USD | 70.015% |
| Immunome, Inc. | -97.02 Million USD | -526.974% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -2604.365% |
| Verona Pharma plc | -220.44 Million USD | -175.966% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -747.953% |
| Shattuck Labs, Inc. | -121.42 Million USD | -401.011% |
| CervoMed Inc. | -7.79 Million USD | -7706.48% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -227.952% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -13811.434% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -361.779% |
| Moolec Science SA | 117.61 Thousand USD | 517331.499% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -26488.86% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 3926.472% |
| AnaptysBio, Inc. | -18.15 Million USD | -3251.589% |
| Design Therapeutics, Inc. | -18.15 Million USD | -3251.774% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -764.363% |
| NeurAxis, Inc. | 145.7 Thousand USD | 417633.974% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 5516.195% |
| Lumos Pharma, Inc. | -28.49 Million USD | -2035.075% |
| Achilles Therapeutics plc | -126.92 Million USD | -379.3% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -747.953% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -92674.008% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -2828.43% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 41821.126% |
| Nutriband Inc. | -251.65 Thousand USD | -241636.57% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -4518.837% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -8076.707% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 278.822% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 2663.08% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -35.952% |
| Palisade Bio, Inc. | -12.06 Million USD | -4943.082% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -333.57% |
| Beam Therapeutics Inc. | -262.72 Million USD | -131.555% |
| Neurogene Inc. | -131.95 Million USD | -361.026% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 2888.536% |
| AEON Biopharma, Inc. | -4.88 Million USD | -12366.127% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -61.284% |
| Sesen Bio, Inc. | -112.55 Million USD | -440.498% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -509.2% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -25811.441% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -1458.825% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -630.466% |
| Athira Pharma, Inc. | -88.99 Million USD | -583.544% |
| Vaccinex, Inc. | -1.28 Million USD | -47131.91% |
| HCW Biologics Inc. | 2.85 Million USD | 21395.625% |
| XOMA Corporation | -29 Million USD | -1997.748% |
| Nektar Therapeutics | 210.24 Million USD | 389.358% |
| Arvinas, Inc. | -313.8 Million USD | -93.865% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 37585.412% |
| Merus N.V. | -192.88 Million USD | -215.395% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 1114.165% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -8668.334% |
| Rezolute, Inc. | -68.16 Million USD | -792.423% |
| Clene Inc. | 3.34 Million USD | 18313.982% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -4513.233% |
| BeyondSpring Inc. | -13.75 Million USD | -4322.734% |
| Synlogic, Inc. | -6.68 Million USD | -9000.18% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 53746.12% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -7095.115% |
| Peak Bio, Inc. | 10.34 Million USD | 5983.343% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -638.106% |
| Krystal Biotech, Inc. | -350.23 Million USD | -73.697% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 590.108% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -259.977% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -19168.903% |
| MannKind Corporation | 143.89 Million USD | 522.76% |
| Ikena Oncology, Inc. | -109.15 Million USD | -457.319% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -7935.227% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -1737.906% |
| Gossamer Bio, Inc. | 180.35 Million USD | 437.305% |
| CohBar, Inc. | -5.93 Million USD | -10157.538% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1945.001% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 13423.412% |
| Legend Biotech Corporation | -949.39 Million USD | 35.923% |
| Mural Oncology plc | -255.84 Million USD | -137.781% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1988.397% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -12814.312% |
| Disc Medicine, Inc. | -358.28 Million USD | -69.796% |
| Champions Oncology, Inc. | 4.81 Million USD | 12742.29% |
| REGENXBIO Inc. | 54.76 Million USD | 1210.771% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -226129.514% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -302.815% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -6650.406% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -653.997% |
| Vaxart, Inc. | -8.24 Million USD | -7281.956% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -1112.33% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -378.389% |
| Cellectis S.A. | -43.85 Million USD | -1287.178% |
| Longeveron Inc. | -2.9 Million USD | -20819.773% |
| Repare Therapeutics Inc. | -107.85 Million USD | -464.026% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 162.821% |
| Inozyme Pharma, Inc. | 12 Million USD | 5167.869% |
| Revolution Medicines, Inc. | -608.2 Million USD | -0.024% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -49359.106% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -129.464% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -305.37% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -3787.947% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -82109.054% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 93.639% |
| Denali Therapeutics Inc. | -74.86 Million USD | -712.592% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -4973.067% |
| Veru Inc. | 4.77 Million USD | 12827.007% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -5309.452% |
| Cingulate Inc. | 3.08 Million USD | 19834.335% |
| Passage Bio, Inc. | 4.58 Million USD | 13368.201% |
| Context Therapeutics Inc. | -14.44 Million USD | -4110.064% |
| Exicure, Inc. | 5.84 Million USD | 10500.872% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -164.067% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -1437.394% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 3977.044% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -934.234% |
| Nuvalent, Inc. | -335.38 Million USD | -81.387% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 35176.551% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -716.77% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -6743.048% |
| OmniAb, Inc. | 9.2 Million USD | 6710.312% |
| Anew Medical, Inc. | 1.43 Million USD | 42568.542% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 3813.564% |
| Lipocine Inc. | -4.75 Million USD | -12694.936% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -453.909% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 4094.137% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -1100.866% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 2543.946% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -8951.436% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -824.16% |
| Ocugen, Inc. | -32.52 Million USD | -1770.628% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -610.893% |
| Q32 Bio Inc. | -37.94 Million USD | -1503.107% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -96770.541% |
| Alumis Inc. Common Stock | -13.52 Million USD | -4396.615% |
| Equillium, Inc. | -22.39 Million USD | -2616.805% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -2279.33% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -1764.564% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -245285.314% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 553.848% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 19122.733% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 185322.612% |
| Dominari Holdings Inc. | 195 Thousand USD | 312072.821% |
| Edesa Biotech, Inc. | -5.26 Million USD | -11450.359% |
| vTv Therapeutics Inc. | -8.91 Million USD | -6722.328% |
| Bio-Techne Corporation | 267.74 Million USD | 327.21% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -3653.143% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -415.138% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -7139.641% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -4708.687% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -148.184% |
| Nkarta, Inc. | 57.29 Million USD | 1161.706% |
| BioCardia, Inc. | 212 Thousand USD | 287056.132% |
| Iterum Therapeutics plc | 13.43 Million USD | 4627.065% |